跳转至内容
Merck
CN
  • Molecular signatures of the evolving immune response in mice following a Bordetella pertussis infection.

Molecular signatures of the evolving immune response in mice following a Bordetella pertussis infection.

PloS one (2014-08-20)
René H M Raeven, Jolanda Brummelman, Jeroen L A Pennings, Olaf E M Nijst, Betsy Kuipers, Laura E R Blok, Kina Helm, Elly van Riet, Wim Jiskoot, Cecile A C M van Els, Wanda G H Han, Gideon F A Kersten, Bernard Metz
摘要

Worldwide resurgence of pertussis necessitates the need for improvement of pertussis vaccines and vaccination strategies. Since natural infections induce a longer-lasting immunity than vaccinations, detailed knowledge of the immune responses following natural infection can provide important clues for such improvement. The purpose was to elucidate the kinetics of the protective immune response evolving after experimental Bordetella pertussis (B. pertussis) infection in mice. Data were collected from (i) individual analyses, i.e. microarray, flow cytometry, multiplex immunoassays, and bacterial clearance; (ii) twelve time points during the infection; and (iii) different tissues involved in the immune responses, i.e. lungs, spleen and blood. Combined data revealed detailed insight in molecular and cellular sequence of events connecting different phases (innate, bridging and adaptive) of the immune response following the infection. We detected a prolonged acute phase response, broad pathogen recognition, and early gene signatures of subsequent T-cell recruitment in the lungs. Activation of particular transcription factors and specific cell markers provided insight into the time course of the transition from innate towards adaptive immune responses, which resulted in a broad spectrum of systemic antibody subclasses and splenic Th1/Th17 memory cells against B. pertussis. In addition, signatures preceding the local generation of Th1 and Th17 cells as well as IgA in the lungs, considered key elements in protection against B. pertussis, were established. In conclusion, molecular and cellular immunological processes in response to live B. pertussis infection were unraveled, which may provide guidance in selecting new vaccine candidates that should evoke local and prolonged protective immune responses.

材料
货号
品牌
产品描述

Sigma-Aldrich
L-谷氨酰胺, meets USP testing specifications, suitable for cell culture, 99.0-101.0%, from non-animal source
Sigma-Aldrich
L-谷氨酰胺, ReagentPlus®, ≥99% (HPLC)
Sigma-Aldrich
羟胺 溶液, 50 wt. % in H2O
SAFC
L-谷氨酰胺
Sigma-Aldrich
L-谷氨酰胺, BioUltra, ≥99.5% (NT)
Sigma-Aldrich
羟胺 溶液, 50 wt. % in H2O, 99.999%
Sigma-Aldrich
L-谷氨酰胺, γ-irradiated, BioXtra, suitable for cell culture
Sigma-Aldrich
L-谷氨酰胺
Supelco
L-谷氨酰胺, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
L-谷氨酰胺, Vetec, reagent grade, ≥99%
Supelco
L-谷氨酰胺, certified reference material, TraceCERT®, Manufactured by: Sigma-Aldrich Production GmbH, Switzerland
Sigma-Aldrich
Mouse MIP-3 α / CCL20 ELISA Kit, for serum, plasma and cell culture supernatant